About UsVardhman Chemtech is the largest and one of the most integrated manufacturers of Bulk Drugs, Intermediates & Fine Chemicals in the Isoxazoles segment of Penicillin i.e. Cloxacillin Sodium, Dicloxacillin Sodium, Flucloxacillin Sodium, Oxacillin Sodium with an annual installed capacity of 750 Mt. All the side chains like CMIC Chloride, DCMIC Chloride, FCMIC chloride, PMIC chloride etc are manufactured in house for captive consumption. The company also manufactures Amoxycillin Trihydrate, Ampicillin Trihydrate, with an annual capacity of 240 Mt at its Unit-I Beta-lactam plant where as Non Beta-lactam products include Gabapentin & Pregabalin. Currently the company manufactures 14 products and their variants. The company has been serving Indian customers for quite a long time. Now, along with that, it has voyaged into exports also, with main focus markets in Far East, Indian Sub-Continent, SAARC, China, Middle East, North Africa, East Africa, West Africa, Latin America & Russian bloc. The company has appointed a dedicated marketing team to tap the opportunities available at the global level. The company targets near 100% growth in exports in the coming years. Not only is the company flexing muscles in marketing and capacity, but also inculcating quality consciousness into the business process, so as to implement Total Quality Management, to provide quality drugs of global level. Mere confirming to the quality standards set is not our aim, but it is to continuously improve in quality, beating the standards in place. The company is on a spree to increase its manufacturing capabilities. Second plant is already in place to increase production so as to serve the increasing demand of our products. Further expansion in manufacturing as well as in our product range is on the cards. To sum up, Vardhman Chemtech Ltd is a young growing company specializing in manufacturing of quality Bulk Drugs, Intermediates & Fine Chemicals which shall strive to achieve excellence on strength of its strong R&D base, motivated team, concern for safety, health and environment and commitment to do business with ethics. Milestones : Year Milestone
1999 Single reactor plant started at D6 for recovery from waste.
2001 Fine Chemicals added to product portfolio like Manganese Dioxide, Sodium 2 Ethyl Hexanoate
2005 Unit-II commissioned at Nimbua. Production of Arethomycin Oxyme started for Ind Swift.
2006 First API i.e. Cloxacillin Sodium started.
2007 CMIC Chloride production started
2008 Dicloxacillin Sodium, Flucloxacillin Sodium, Gabapentin included in the product portfolio.
2009 Product portfolio further expanded to include Pregabalin Strategy :
- Have scale of economy & backward integration to be world leaders in selected products.
- Approaching major international companies for strategic ties.
- Identifying newer overseas markets.
- Continuously working to add new products having good demand.
Strengths :
- One of the most integrated manufacturers in the world
- Timely execution of the orders
- Customized product according to the customer needs
- Sole supplier to Ranbaxy, of critical raw material for Iso Tretnoin and Medazolin for eight years.
- Preferred vendor to DSM for key Intermediate of Cloxacillin Sodium.
- Continuous expansion of produ
|
Processing...
